ANIX

Anixa Biosciences Inc

Jun 16 • 04:00PM ET

2.61

+0.13 5.24 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: ATYR COYA CYPH INO LONA NRXS CGTX KLRS NRXP KALA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.30	Insider Own	5.38%	Shs Outstand	33.92M	Perf Week	8.75%
Market Cap	88.80M	Forward P/E	-	EPS next Y	-0.35	Insider Trans	1.72%	Shs Float	32.19M	Perf Month	-7.45%
Enterprise Value	74.04M	PEG	-	EPS next Q	-0.09	Inst Own	14.97%	Short Float	3.15%	Perf Quarter	-9.69%
Income	-10.03M	P/S	-	EPS this Y	1.47%	Inst Trans	-2.95%	Short Ratio	8.69	Perf Half Y	-27.09%
Sales	0.00M	P/B	6.12	EPS next Y	-4.48%	ROA	-63.02%	Short Interest	1.01M	Perf YTD	-16.35%
Book/sh	0.43	P/C	6.49	EPS next 5Y	-3.32%	ROE	-65.70%	52W High	5.46 -52.17%	Perf Year	-30.40%
Cash/sh	0.40	P/FCF	-	EPS past 3/5Y	9.05% 5.67%	ROIC	-68.66%	52W Low	2.32 12.50%	Perf 3Y	-23.24%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.99% 5.66%	Perf 5Y	-37.11%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	19.64%	Oper. Margin	-	ATR (14)	0.16	Perf 10Y	-22.32%
Dividend Ex-Date	-	Quick Ratio	9.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	48.52	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	9.79	EPS Q/Q	13.51%	SMA20	0.69%	Beta	0.61	Target Price	11.50
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	-6.54%	Rel Volume	2.08	Prev Close	2.48
Employees	4	LT Debt/Eq	0.01	Earnings	Mar 13	SMA200	-21.04%	Avg Volume	116.62K	Price	2.61
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	10.21% -	Trades		Volume	238,202	Change	5.24%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)